IGF1 and Duchenne muscular dystrophy: A mouse model of the fatal pediatric disease Duchenne muscular dystrophy (DMD) showed that TNF-mediated activation of JNK induces conformational changes in the insulin receptor substrate (IRS)-1, thereby disrupting downstream events after IGF-1/IGF-1 receptor binding [41].